Steve Paul

Vice President of Sales at Vertos Medical, Inc.

Steve Paul

Steve Paul

Vice President of Sales at Vertos Medical, Inc.

Overview
RelSci Relationships

1537

Birthday

1972

Age

47

Contact Data
Trying to get in touch with Steve Paul? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Steve Paul likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Director at CathWorks Ltd.

Relationship likelihood: Average

President, Chief Executive Officer & Director at Vertos Medical, Inc.

Relationship likelihood: Average

Chief Financial Officer & Vice President-Finance at Vertos Medical, Inc.

Relationship likelihood: Average

Vice President of Marketing & Sales at ReShape Medical, Inc.

Relationship likelihood: Average

Vice President of Clinical Research at Vertos Medical, Inc.

Relationship likelihood: Average

Vice President-Operations, Research & Development at Vertos Medical, Inc.

Relationship likelihood: Average

Vice President-Clinical Research at Vertos Medical, Inc.

Relationship likelihood: Average

Vice President, Sales at Vertos Medical, Inc.

Relationship likelihood: Average

Former Financial Controller at Vertos Medical, Inc.

Relationship likelihood: Average

Former Controller at Vertos Medical, Inc.

Relationship likelihood: Average

Paths to Steve Paul
Potential Connections via
Relationship Science
You
Steve Paul
Vice President of Sales at Vertos Medical, Inc.
Education
B.A. in Political Science

The University of California, Santa Barbara (commonly referred to as UC Santa Barbara or UCSB) is a public research university and one of the 10 general campuses of the University of California system. The main campus is located on a 1,022-acre (414 ha) site near Goleta, California, United States, 8 miles (13 km) from Santa Barbara and 100 miles (160 km) northwest of Los Angeles. Tracing its roots back to 1891 as an independent teachers' college, UCSB joined the University of California system in 1944 and is the third-oldest general-education campus in the system. UCSB traces its origins back to the Anna Blake School which was founded in 1891 and offered training in home economics and industrial arts. The Anna Blake School was taken over by the state in 1909 and became the Santa Barbara State Normal School. Intense lobbying by an interest group in the City of Santa Barbara, led by Thomas Storke and Pearl Chase, persuaded the State Legislature, Governor Earl Warren, and the Regents of the University of California to move the State College over to the more research-oriented University of California system in 1944. The State College system sued to stop the takeover, but the Governor did not support the suit. A state initiative was passed, however, to stop subsequent conversions of State Colleges to University of California campuses. From 1944 to 1958 the school was known as Santa Barbara College of the University of California, before taking on its current name. When the vacated Marine Corps training station in Goleta was purchased for the rapidly-growing college, Santa Barbara City College moved into the vacated State College buildings.

Career History
Vice President of Sales
2019 - Current

Vertos Medical, Inc. develops and markets minimally invasive devices for the treatment of lumbar spinal stenosis (LSS). The firm offers mild which offers an outpatient, minimally invasive, and fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. mild also treats LSS by restoring space in the spinal canal using specialized mild devices to remove hypertrophic ligamentum flavum through a treatment portal. Its products include mild tissue sculpter, mild portal, mild bone sculpter rongeur, and mild surgical clamp. The company was founded by David Solsberg and Donald F. Schomer in 2005 and is headquartered in Aliso Viejo, CA.

Vice President, Sales & Commercial Operations
2012 - Prior

Breg, Inc. manufactures and sells sports medicine products and services. Its products include knee braces, cold therapy, hip braces, shoulder braces, elbow and wrist braces, Orthopedic Practice Solutions, canes, crutches and walkers. The company was founded in 1989 and is headquartered in Carlsbad, CA.

Executive Vice President of Sales, US Acute Care
2008 - Prior

Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® SET Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb®) monitoring technology. These new rainbow® technologies are expected to open new markets and significantly expand the company’s growth opportunities. Joe Kiani founded Masimo in 1989 as a private "garage start-up" company because he was convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry. Today, Masimo has grown into a successful publicly traded medical technology company employing over 2,500 people worldwide with product revenues that have increased 4-fold in the last five years. In addition, the company has technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe including Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs, and Zoll. Masimo is not only the inventor of Measure-through Motion and Low Perfusion pulse oximetry and Pulse CO-Oximetry technologies, but is also the market-leading pulse oximetry technology solution. In 1995, Masimo debuted Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo SET—a breakthrough in pulse oximetry technology that virtually eliminated false alarms and increased pulse oximetry’s ability to detect life-threatening events. More than 100 independent and objective studies demonstrate that Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow® SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that measures many blood constituents that previously required invasive procedures. Masimo rainbow SET continuously and noninvasively measures total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and pleth variability index (PVI®), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), enabling early detection and treatment of potentially life-threatening conditions. For more than 20 years now, Masimo has been focused on a singular mission—to create noninvasive patient monitoring technologies that are more effective and reliable and to improve patient outcomes and reduce the cost of care by bringing these technologies to new sites and applications. The result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steve Paul. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steve Paul's profile does not indicate a business or promotional relationship of any kind between RelSci and Steve Paul.